We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of its AI-enabled Precise Suite [1] solution for the company’s Incisive CT
Sight Sciences, Inc., a growth-stage medical device company focused on addressing the underlying causes of the world’s most prevalent eye conditions, today announced U.S. Food and Drug Administration
Drug developers have a new bioluminescent tool to characterize how potential pharmaceuticals behave in biologically relevant systems. A new primary cell bioassay from Promega Corporation uses peripheral blood
Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM Capital
B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb®
ViaCyte, Inc., a clinical stage regenerative medicine company, and W. L. Gore & Associates, Inc. (“Gore”), a leading global materials science company with expertise in medical device and drug
Epsilon Imaging, a visualization and analysis software provider transforming cardiac diagnostic workflow with strain imaging, today announced a partnership with Siemens Healthineers, a leading developer of medical imaging
RGF® Environmental Group, Inc., a leading environmental design and manufacturing company, has released the results of a third-party test that proves the PHI-PKG14 PHI-CELL® product with Photohydroionization® technology inactivates greater
Recently BioBarica received the approval of its Hyperbaric Chambers by the United States Food and Drug Administration (FDA). The company manufactures and commercializes its medical devices in more
New England Biolabs (NEB®) today released three kits based on the ARTIC Network protocols for multiplexed amplicon-based sequencing of viral RNA: NEBNext® ARTIC SARS-CoV-2 Library Prep Kit and